អង្គការព្រហ្មអភិវឌ្ឍសុខភាព
Prom Health Development
Home
About Us
History
Our Mission
Board of Director
Partnerships
Services
Resources
News and Guidelines
Published Journal Articles
Job Opportunities
Contact Us
Menu
Home
About Us
History
Our Mission
Board of Director
Partnerships
Services
Resources
News and Guidelines
Published Journal Articles
Job Opportunities
Contact Us
Donate
Health Quality Services
2014 Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval
72